Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2005
09/07/2005CN1217932C Antibacterial agents
09/07/2005CN1217927C Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
09/07/2005CN1217926C Novel vitamin D analogues
09/07/2005CN1217920C Compounds to treat Alzheimer disease
09/07/2005CN1217699C Preventives or remedies for arrhythmia
09/07/2005CN1217697C Peptide antagonists of zonulin and methods for use of same
09/07/2005CN1217696C Health caring and face nursing composition of natural materials
09/07/2005CN1217685C Chinese medicine for sub-health and its preparing method
09/07/2005CN1217660C IL-8 receptor antagonists
09/07/2005CN1217657C Method of improving survival of patients
09/06/2005US6941229 Method of designing agonists and antagonists to EGF receptor family
09/06/2005US6939990 Derivatives of dicarboxylic acid having pharmaceutical properties
09/06/2005US6939897 Method and composition for inhibiting arteriosclerosis
09/06/2005US6939891 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
09/06/2005US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1)
09/06/2005US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
09/06/2005US6939876 Mixture of analgesic and addition reducting compound of a gamma-aminobutyric acid
09/06/2005US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders
09/06/2005US6939874 Substituted pyrimidinyl derivatives and methods of use
09/06/2005US6939872 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
09/06/2005US6939867 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents
09/06/2005US6939862 Method for transferring nucleic acid into striated muscles
09/06/2005US6939860 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds
09/06/2005US6939859 Skin preparations for external use
09/06/2005US6939858 For therapy and prophylaxis of hyperglycemia
09/06/2005US6939853 Administering glucagon-like peptide 1 (GLP-1) compound and an effective amount of an antidyslipidemic drug for therapy of dyslipidemia
09/06/2005US6939840 Disinfectant
09/06/2005US6939679 NADE binding proteins
09/06/2005US6939570 Composition and methods for treating Alzheimer's disease and other amyloidoses
09/06/2005US6939568 Hydrated dressing containing metal microbiocide
09/06/2005US6939565 Protease inhibitors of the coagulation cascade isolated from Dysidea sponges
09/06/2005US6939562 Collagen/polysaccharide bilayer matrix
09/06/2005US6939550 Storage stability
09/06/2005US6939539 present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons
09/06/2005CA2250395C Eprosartan dihydrate and a process for its production and formulation
09/06/2005CA2217479C Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them
09/06/2005CA2137673C Novel 4-[3-benzofuranyl]piperidinyl and 4-[3-benzothienyl]piperidinyl derivatives
09/06/2005CA2105652C Reducing wound scarring with antibodies to growth factors
09/06/2005CA2086137C Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same
09/03/2005CA2486341A1 Supplement foods and pharmaceuticals
09/01/2005WO2005080976A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia
09/01/2005WO2005080582A1 Cytoplasmic localization dna and rna
09/01/2005WO2005080553A1 Cell-associated physiologically active substance and cell culture supplement
09/01/2005WO2005080392A1 Pyrazoloquinolone derivative and use thereof
09/01/2005WO2005080385A1 Indanol derivative
09/01/2005WO2005080384A2 Benzimidazole derivative and use as aii receptor antagonist
09/01/2005WO2005080378A1 Fused pyridazine derivatives
09/01/2005WO2005080330A1 Heteroarylphenylurea derivative
09/01/2005WO2005079847A1 NUCLEAR TRANSFER PROMOTER FOR Cdc42 PROTEIN AND METHOD OF SCREENING THE SAME
09/01/2005WO2005079846A1 NUCLEAR TRANSFER PROMOTER FOR Rac PROTEIN AND METHOD OF SCREENING THE SAME
09/01/2005WO2005079824A1 Beverage or drug containing bamboo extract as main ingredient
09/01/2005WO2005079813A1 Composition for nkt cell activation
09/01/2005WO2005079789A1 Combinatorial therapy with an acetylcholinesterase inhibitor and (3ar)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate
09/01/2005WO2005079783A1 Medicine capable of inhibiting activation of transcription factor klf5
09/01/2005WO2005079780A1 Amidine derivatives for treating amyloidosis
09/01/2005WO2005079774A2 Management of ophthalmologic disorders, including macular degeneration
09/01/2005WO2005079164A2 5α-REDUCTASE INHIBITORS
09/01/2005WO2002083873A3 Enzymes
09/01/2005US20050192336 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor
09/01/2005US20050192334 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
09/01/2005US20050192332 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
09/01/2005US20050192327 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor
09/01/2005US20050192326 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril
09/01/2005US20050192322 Calcium blockers to treat proliferative vitreoretinopathy
09/01/2005US20050192316 Aryl aniline beta2 adrenergic receptor agonists
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005US20050192308 N-but-E-enyl norbuprenorphine and methods of use
09/01/2005US20050192306 Pyrimidine derivatives as selective inhibitors of COX-2
09/01/2005US20050192304 Rho-kinase inhibitors
09/01/2005US20050192284 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use
09/01/2005US20050192274 Combinations of drugs for the treatment of neoplastic disorders
09/01/2005US20050192259 A sustained release formulation of an aldosterone antagonist orally administered about 6-12 hours prior to the acrophase to provide a profile of plasma drug concentration corresponding to the diurnal cycle of plasma aldosterone concentration; hypotensive agents; circadi rhythm; cardiovascular disorders
09/01/2005US20050192235 Compositions and methods for treating or preventing diseases of body passageways
09/01/2005US20050192232 E.g.,N[(R)-3-dodecanoyloxytetradecanoylamino]-C-aspartic acid, alpha-N-{(4R)-5-hydroxy-4-[(R)-3-hydroxytetradecanoyl- amino]pentyl}amide; grafting antigens to modulate immune response and on a pharmaceutical carrier or antibiotic to enhance therapeutic effect or targetting aqueous conjugate injections
09/01/2005US20050191713 Medicinal use of histone deacetylase inhibitor and method of evaluating antitumor effect thereof
09/01/2005US20050191696 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
09/01/2005US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
09/01/2005US20050191617 Pramyxovirusl vectors encoding antibody and utilization thereof
09/01/2005US20050191354 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent
09/01/2005US20050191323 Pharmaceutical formulations comprising paclitaxel, derivatives and pharmaceutically acceptable salts thereof
09/01/2005US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
09/01/2005US20050191288 Administering to patient before or simultaneously with surgery at least one heparinase enzyme, wherein heparinase enzyme decreases localized inflammatory response in the tissue of the patient
09/01/2005US20050191275 Method for short-term and long-term drug dosimetry
09/01/2005US20050191268 Polyphenol-and protein-containing extracts of winemaking residues, and methods of using the same
09/01/2005US20050191267 Mulberry extract; whitening effects for darkened skin through antityrosinase activity, antioxidant and anti-inflammatory properties
09/01/2005CA2557539A1 Indanol derivative
09/01/2005CA2557158A1 Prophylactic antimigraine agents
09/01/2005CA2556214A1 Combination of an nmda receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other cns disorders
09/01/2005CA2555261A1 Management of ophthalmologic disorders, including macular degeneration
09/01/2005CA2555084A1 Combinatorial therapy with an acetylcholinesterase inhibitor and (3ar)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate
09/01/2005CA2552094A1 Amidine derivatives for treating amyloidosis
09/01/2005CA2537079A1 Fluorene derivative
09/01/2005CA2526905A1 Composition for nkt cell activation
09/01/2005CA2498966A1 Novel pyrazole analogs acting on cannabinoid receptors
09/01/2005CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production
08/2005
08/31/2005EP1568779A1 HSV strains for the oncolytic treatment of cancer
08/31/2005EP1568772A2 Human growth hormone variants
08/31/2005EP1568771A2 Human growth hormone variants
08/31/2005EP1568704A1 Novel 2' ,5' -oligoadenylic acid analogues
08/31/2005EP1568699A1 1,3-dihydroimidazole fused-ring compound
1 ... 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 ... 1564